Clicky

LIVZON PHARMAC. GRP H YC1(LP6)

Description: Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers drug preparation products, including Ilaprazole enteric coated tablets to treat duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection to treat endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precocious puberty; and Urofollitropin for injection to treat anovulation and sufferers. It also provides Perospirone hydrochloride tablets to treat schizophrenia; Shenqi Fuzheng Injection to treat weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for treating lung and stomach cancer; anti-viral granules used for clearing heat, eliminating dampness, cooling blood, and detoxifying to treat upper respiratory tract infection and influenza; Tocilizumab injection to treat rheumatoid arthritis; and Recombinant SARSCoV-2 fusion protein vaccine used to prevent diseases caused by SARS-CoV-2 infection. In addition, the company offers antinuclear antibody test kit, used for the detection of common anti-nuclear and anti-antibodies in the autoimmune diseases; nucleic acid test kits for human immunodeficiency virus type 1; interferon-gamma release assays test kits, used to determine whether the human body is infected with Mycobacterium tuberculosis; diagnostic kit for IgM antibody to mycoplasma pneumonia. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. Livzon Pharmaceutical Group Inc. was founded in 1985 and is headquartered in Zhuhai, China.


Keywords: Pharmaceutical Products Disease Medication Antibodies Antibiotics Active Pharmaceutical Ingredients Autoimmune Disease Infection Monoclonal Antibodies Rheumatoid Arthritis Influenza Schizophrenia Injection Immunosuppressants Endometriosis Pharmaceutical Raw Materials Upper Respiratory Tract Infection Vertigo Biologic Products Duodenal Ulcers Tiredness Anovulation Disease Modifying Antirheumatic Drugs Ilaprazole Laprazole Leuprorelin Leuprorelin Acetate Lung And Stomach Cancer Peptic Ulcer Hemorrhage Reflux Esophagitis Urofollitropin Central Precocious Puberty Mycobacterium Tuberculosis Tocilizumab Breast And Prostate Cancer Drug Preparation Products

Home Page: www.livzon.com.cn

Headquarters Building
Zhuhai, 519090
China
Phone: 86 75 6813 5888


Officers

Name Title
Mr. Yanggang Tang President & Executive Director
Mr. Guoxiang Xu Executive Vice Chairman & VP of Sales
Ms. Yanxia Si VP & CFO
Mr. Liang Yang VP, Secretary to the Board & Company Secretary
Mr. Daihong Yang Vice President
Ms. Yuxuan Huang Vice President
Mr. Jun Du Vice President
Jianing Liu Chief Investment Officer & Head of BD Dept.
Ms. Jianying Zhuang Head of Accounting Department
Mr. Maolin Wang Chief Supervisor and GM of Legal & Compliance

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 10.8966
Price-to-Book MRQ: 1.5916
Price-to-Sales TTM: 0.3414
IPO Date:
Fiscal Year End: December
Full Time Employees: 8933
Back to stocks